Clinical Trial Update: Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating low-dose edoxaban in elderly patients with atrial fibrillation and a history of ischemic stroke; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Savaysa (edoxaban)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Elderly, Atrial Fibrillation (AF) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING